Similar Papers

Paper Title
Journal
Date
Author
Overexpression of Oncoprotein 18 Correlates with Poor Differentiation in Lung Adenocarcinomas
Guoan Chen ... David E Misek
Molecular & Cellular Proteomics | VOL. 2
Guoan Chen, et. al.Guoan Chen ... David E Misek
01 Feb 2003
Overexpression of lncRNA A2M-AS1 inhibits cell growth and aggressiveness via regulating the miR-587/bone morphogenetic protein 3 axis in lung adenocarcinoma.
Hongfei Guo ... Ting Xiao
Human & experimental toxicology | VOL. 41
Hongfei Guo, et. al.Hongfei Guo ... Ting Xiao
01 Jan 2021
Role of GSDM family members in airway epithelial cells of lung diseases: a systematic and comprehensive transcriptomic analysis.
Xuanqi Liu ... Xiangdong Wang
Cell biology and toxicology | VOL. 39
Xuanqi Liu, et. al.Xuanqi Liu ... Xiangdong Wang
18 Jul 2023
CircSCUBE3 promoted ferroptosis to inhibit lung adenocarcinoma progression.
Hongye Fu ... Qiong Zhao
Cellular and molecular biology (Noisy-le-Grand, France) | VOL. 70
Hongye Fu, et. al.Hongye Fu ... Qiong Zhao
29 Feb 2024
View more papers

More From: Clinical and Translational Medicine

Paper Title
Journal
Date
Author
Predictive nomogram integrating radiomics and multi-omics for improved prognosis-model in cholangiocarcinoma.
Yunlu Jia ... Jian Ruan
Clinical and translational medicine | VOL. 15
Yunlu Jia, et. al.Yunlu Jia ... Jian Ruan
01 Jan 2025
Transforming precision medicine: The potential of the clinical artificial intelligent single-cell framework.
Christian Baumgartner ... Dagmar Brislinger
Clinical and translational medicine | VOL. 15
Christian Baumgartner, et. al.Christian Baumgartner ... Dagmar Brislinger
01 Jan 2025
How the brain produces generalized fear.
Hui-Quan Li ... Nicholas C Spitzer
Clinical and translational medicine | VOL. 15
Hui-Quan Li, et. al.Hui-Quan Li ... Nicholas C Spitzer
01 Jan 2025
Deciphering the pseudouridine nucleobase modification in human diseases: From molecular mechanisms to clinical perspectives.
Shiheng Jia ... Kai Li
Clinical and translational medicine | VOL. 15
Shiheng Jia, et. al.Shiheng Jia ... Kai Li
01 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.